{{Rsnum
|rsid=8094493
|Gene=MBD2
|Chromosome=18
|position=54174021
|Orientation=plus
|GMAF=0.4275
|Gene_s=MBD2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 22.1 | 46.0 | 31.9
| HCB | 25.5 | 38.7 | 35.8
| JPT | 18.6 | 39.8 | 41.6
| YRI | 37.4 | 46.3 | 16.3
| ASW | 23.2 | 57.1 | 19.6
| CHB | 25.5 | 38.7 | 35.8
| CHD | 18.3 | 35.8 | 45.9
| GIH | 11.0 | 32.0 | 57.0
| LWK | 21.1 | 55.0 | 23.9
| MEX | 12.1 | 27.6 | 60.3
| MKK | 17.3 | 46.8 | 35.9
| TSI | 21.6 | 46.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22258532
|Title=A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}